These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8989819)

  • 1. Determinants of substrate specificity for factor XIII.
    McDonagh J; Fukue H
    Semin Thromb Hemost; 1996; 22(5):369-76. PubMed ID: 8989819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
    Lewis KB; Teller DC; Fry J; Lasser GW; Bishop PD
    Biochemistry; 1997 Feb; 36(5):995-1002. PubMed ID: 9033388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization.
    Devine DV; Bishop PD
    Semin Thromb Hemost; 1996; 22(5):409-13. PubMed ID: 8989824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
    Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
    Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin.
    Matsuka YV; Anderson ET; Milner-Fish T; Ooi P; Baker S
    Biochemistry; 2003 Dec; 42(49):14643-52. PubMed ID: 14661977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y; Aoki N
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
    Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
    Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
    Mimuro J; Kimura S; Aoki N
    J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.
    Koncz Z; Bagoly Z; Haramura G; Mezei ZA; Muszbek L
    Thromb Res; 2012 Sep; 130(3):528-34. PubMed ID: 22704462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of factor XIIIa activity on human whole blood clot lysis in vitro.
    Jansen JW; Haverkate F; Koopman J; Nieuwenhuis HK; Kluft C; Boschman TA
    Thromb Haemost; 1987 Apr; 57(2):171-5. PubMed ID: 2440124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of the factors in wound healing for the origin of chronic subdural hematoma--fibronectin and its related substances].
    Nishida S
    No To Shinkei; 1992 Jun; 44(6):565-70. PubMed ID: 1389564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking of alpha 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor.
    Tamaki T; Aoki N
    Biochim Biophys Acta; 1981 Oct; 661(2):280-6. PubMed ID: 7295739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of blood coagulation factor XIIIa-mediated cross-linking between fibronectin and collagen by polyamines.
    Mosher DF; Schad PE; Kleinman HK
    J Supramol Struct; 1979; 11(2):227-35. PubMed ID: 548650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of alpha 2-plasmin inhibitor].
    Mimuro J; Aoki N
    Rinsho Byori; 1985 Feb; Spec No 61():97-105. PubMed ID: 2860263
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity of fibronectin--fibrin cross-linking.
    Mosher DF; Johnson RB
    Ann N Y Acad Sci; 1983 Jun; 408():583-94. PubMed ID: 6135382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.